FDA Orange Book · active-ingredient family
Tinidazole
Tinidazole is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:TINDAMAX · NDA 021618
1
Brand (NDA)
4
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TINDAMAXRLD×2 | MISSION PHARMA | NDA 021618 | AB | May 17, 2004 |
Generic (ANDA) products (4)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TINIDAZOLE×2 | EDENBRIDGE PHARMS | ANDA 203808 | AB | Aug 04, 2015 | |
| TINIDAZOLE×2 | UNIQUE | ANDA 202489 | AB | Oct 09, 2013 | |
| TINIDAZOLE×2 | CHARTWELL RX | ANDA 202044 | AB | Apr 30, 2012 | |
| TINIDAZOLE×2 | HIKMA | ANDA 201172 | — | Apr 30, 2012 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Tinidazole — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

